Dynamiker Cryptococcal Antigen Lateral Flow Assay(LFA)

Specification

Guideline

WHO guidelines for the Diagnosis, Prevention, and Management of Cryptococcal Disease in Hiv-Infected Adults, Adolescents, and Children, 2018

Screening for cryptococcal antigen followed by preemptive antifungal therapy among cryptococcal antigen-positive people to prevent the development of invasive cryptococcal disease is recommended before initiating or reinitiating ART for adults and adolescents living with HIV who have a CD4 cell count<100 cells/mm3 (strong recommendation; moderate-certainty evidence) and may be considered at a higher CD4 cell count threshold of <200 cells/mm3 (conditional recommendation; moderate-certainty evidence).